Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bank of Saga Ltd. ( (JP:8395) ) has issued an announcement.
The Bank of Saga Ltd. has sold all 2,356,000 common shares it held in Hisamitsu Pharmaceutical Co., Inc. into a tender offer conducted by TAIYO KOSAN CO., INC., at a price of ¥6,082 per share. The transaction, to be settled on February 27, 2026, results in a total sale amount of ¥14,329 million and a gain on sale of ¥12,048 million, eliminating the bank’s equity stake in Hisamitsu.
As a result of this divestment, the Bank of Saga plans to record a significant gain on sale of equity securities on a consolidated basis in the fiscal year ending March 31, 2026. The bank is currently reviewing its consolidated earnings forecasts for that fiscal year in light of the tender offer proceeds and other factors, indicating potential revisions that may affect shareholder expectations and financial performance indicators once finalized.
The most recent analyst rating on (JP:8395) stock is a Buy with a Yen5286.00 price target. To see the full list of analyst forecasts on Bank of Saga Ltd. stock, see the JP:8395 Stock Forecast page.
More about Bank of Saga Ltd.
The Bank of Saga Ltd. is a regional financial institution based in Saga City, Japan, listed on the Tokyo Stock Exchange Prime and Fukuoka Stock Exchange under securities code 8395. It provides banking and related financial services to local and broader Japanese markets, managing an investment portfolio that includes equity securities of other listed companies as part of its asset management strategy.
Average Trading Volume: 71,810
Technical Sentiment Signal: Buy
Current Market Cap: Yen82.71B
See more insights into 8395 stock on TipRanks’ Stock Analysis page.